• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Livongo Launches Cellular-Enabled Blood Pressure Monitoring System

by Fred Pennic 09/17/2018 Leave a Comment

Livongo Health
Digital health startup Livongo, today announced the first cellular-enabled blood pressure monitoring system in the U.S. that allows for easy checking and reporting from home, eliminating the so-called ‘White Coat’ syndrome that leads to unnecessary prescriptions for high blood pressure, and it also enables real-time insights and Health Nudges delivered when it is most effective. 

The cellular-enabled monitoring system allows blood pressure data to transfer seamlessly from ‘Cuff to Cloud’TM. Members receive personalized, insight-driven messaging (insights and Health NudgesTM) based on blood pressure data and trends. Members are also supported in real-time through digital alerts and virtual coaching from a team of licensed professionals certified in chronic-condition management.

“Just as we did with diabetes, Livongo wants to make it easier for people to stay healthy by checking their blood pressure, receiving real-time personalized feedback, sharing the information with their physician and other members of their connected care community from home, thereby avoiding a rise in blood pressure that can come with visiting a doctor,” said Amar Kendale, Chief Product Officer, Livongo. “We’re proud to introduce the first cellular-enabled blood pressure monitoring system to market in the U.S. and to add this capability to our comprehensive platform for people with all kinds of chronic conditions. This allows us to treat the whole person and the challenges they face in a seamless manner.”  

Eighty-one percent of people in the initial cohort, who have both diabetes and hypertension, reduced their blood pressure. Individuals with mean blood pressures greater than 130/80 decreased their systolic blood pressure by nine mmHg on average1 lowering their risk of stroke and heart attacks by at least 35% and 25%, respectively2. In addition to strong clinical results, participants really liked the product, measured by a net promoter score of +76. Many of the early adopters of the solution also reported high adoption, with rates of 60 percent of eligible members enrolling in the program in the first 30 days1.

“As the first organization with an integrated offering that is delivering both clinical and financial results in the marketplace, Livongo is leading the way in empowering people to manage multiple chronic conditions,” said Glen Tullman, Chief Executive Officer of Livongo. “Our early results show that by addressing the health of the whole person with a personalized approach and a seamless experience, we are making a difference in the lives of people who need it most.” 

Tagged With: Blood Pressure Monitors, Livongo Health

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |